跳转至内容
Merck
CN

I8641

Inhibin α-Subunit Fragment 1-32 porcine

≥90% (HPLC)

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式(希尔记法):
C163H248N48O43S
化学文摘社编号:
分子量:
3600.07
UNSPSC Code:
51111800
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


biological source

Porcine

assay

≥90% (HPLC)

form

powder

composition

Peptide content, ~60%

color

white

solubility

water: soluble 1 mg/mL, clear, colorless

storage temp.

−20°C

Application

An immunogenic fragment of inhibin.
Inhibin α-subunit fragment 1-32 porcine has been used in the ELISA (enzyme-linked immunosorbent assay) for detection of the inhibin antibody levels.

Biochem/physiol Actions

Inhibins are glycoproteins made of an α subunit and a β subunit. They suppress FSH (follicle stimulating hormone) secretion from the pituitary and also participate in control of gonadal functions. Inhibin α (INHA) is present in adrenal glands, pituitary gland, liver and placenta. It plays a significant role in male fertility.


pictograms

Health hazard

signalword

Danger

hcodes

Hazard Classifications

Repr. 1B

存储类别

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type P3 (EN 143) respirator cartridges

法规信息

新产品

此项目有



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



A J Mason et al.
Nature, 318(6047), 659-663 (1985-12-19)
Inhibin, a specific and potent polypeptide inhibitor of the secretion of follicle-stimulating hormone (FSH), of gonadal origin and thus a potential contraceptive, may constitute a missing link in the mechanism controlling the differential secretion of the pituitary gonadotropins. Inhibin-like bioactivity
F M Hui et al.
Genetics and molecular research : GMR, 13(3), 6113-6125 (2014-08-15)
DNA vaccination has been studied intensively as a potential vaccine technology. We evaluated the effect of an attenuated Salmonella choleraesuis-mediated inhibin DNA vaccine in rats. First, 15 rats were treated with different doses of an inhibin vaccine to evaluate vaccine
Pawel Walentowicz et al.
PloS one, 9(3), e90575-e90575 (2014-03-07)
of our study was to examine serum inhibin A and inhibin B concentrations in ovarian cancer patients in relation to clinicopathological features and 5-year survival. We enrolled 90 epithelial ovarian cancer patients in our study, aged 45-81 years, who underwent